gene, functions in terminal differentiation of neurons (Johnson et al., 1990; Guillemot et al., 1993; Lee et al., We have isolated a novel basic helix-loop-helix (bHLH) 1995). Thus, multiple bHLH genes positively regulate gene homologous to the Drosophila proneural gene vertebrate neurogenesis at different stages. In contrast, atonal, termed ATH-3, from Xenopus and mouse. ATH-3
HES-1, a mammalian bHLH gene homologous to Drosois expressed in the developing nervous system, with phila hairy and E(spl), is expressed in neural precursor high levels of expression in the brain, retina and cranial cells and acts as a negative regulator of neurogenesis ganglions. Injection of ATH-3 RNA into Xenopus (Akazawa et al., 1992; Sasai et al., 1992) . Forced expresembryos dramatically expands the neural tube and sion of HES-1 blocks neuronal differentiation in the brain induces ectopic neural tissues in the epidermis but (Ishibashi et al., 1994) and retina . inhibits non-neural development. This ATH-3-induced
Conversely, a HES-1-null mutation accelerates neuronal neural hyperplasia does not require cell division, differentiation and results in severe anomalies of the brain indicating that surrounding cells which are normally and eye .
non-neural types adopt a neural fate. In a Xenopus
Thus, HES-1 prevents premature neurogenesis and reguanimal cap assay, ATH-3 is able to convert ectodermal lates brain and eye morphogenesis.
cells into neurons expressing anterior markers without
The exact mechanism by which HES-1 prevents premainducing mesoderm. Interestingly, a single amino acid ture neurogenesis is unclear, but it is likely that HES-1 change from Ser to Asp in the basic region, which antagonizes bHLH genes that positively regulate neuromimics phosphorylation of Ser, severely impairs the genesis, as in the case of Drosophila. Interestingly, expresanterior marker-inducing ability without affecting sion of Mash-1 is up-regulated in HES-1-null mice general neurogenic activities. These results provide , suggesting that Mash-1 up-regulaevidence that ATH-3 can directly convert non-neural tion may contribute to premature neurogenesis. However, or undetermined cells into a neural fate, and suggest null mutation of Mash-1 does not cause any apparent that the Ser residue in the basic region may be critical abnormalities in the central nervous system (CNS) for the regulation of ATH-3 activity by phosphoryl
Introduction
Drosophila proneural gene atonal (Jarman et al., 1993 (Jarman et al., , 1994 . In Xenopus, ATH-3 expression starts in the preIn Drosophila, neural development is controlled positively sumptive CNS during neural induction and persists at a or negatively by multiple basic helix- loop-helix (bHLH) high level in the brain and retina. In addition, ATH-3 is genes (Campos-Ortega and Jan, 1991; Jan and Jan, 1993;  able to promote neural development at the expense of Jarman et al., 1993 Jarman et al., , 1994 . For example, achaete-scute adjacent non-neural tissues. In the animal cap assay, complex (AS-C) and atonal are proneural genes, and the ATH-3 can directly convert ectodermal cells into neurons former is required for external sensory organ development expressing anterior markers. Interestingly, a Ser→Asp while the latter is required for photoreceptor and mutation in the basic region, which mimics phosphorylchordotonal organ development. In contrast, hairy and ation of Ser, impairs anterior marker-inducing abilities Enhancer of split [E(spl)] inhibit neural development by without losing the general neurogenic activity. These antagonizing the proneural genes.
As in Drosophila, vertebrate neurogenesis is also conresults indicate that ATH-3 can act as a vertebrate proneural gene and that ATH-3 activity may be regulated by phosprobe, Xenopus and mouse cDNA libraries were screened to determine the full-length coding sequences. phorylation of Ser in the basic region.
Xenopus and mouse ATH-3 consisted of 315 ( Figure  1A ) and 330 amino acid residues ( Figure 1B) , respectively, and shared 93% identity in the bHLH domain (Figure 1 , Results underlined, and Figure 2B ). The structural similarity Structural analysis of Xenopus and mouse ATH-3 extended to the upstream and downstream regions of the PCR with degenerate oligonucleotide primers was carried bHLH domain, with an overall identity of 67% (Figure out to search for a novel bHLH gene expressed in the 2A). In addition, ATH-3 showed significant sequence developing nervous system. We obtained a PCR fragment homology to MATH-1 , MATH-2/ from a bHLH gene, which was termed ATH-3 because of NEX-1 (Bartholomä and Nave, 1994; Shimizu et al. , structural similarity to the Drosophila proneural gene 1995), NeuroD/BETA2 (Lee et al., 1995; Naya et al., atonal . This PCR fragment was used to screen a mouse 1995), NDRF/KW8 (Kume et al., 1996; Yasunami et al., genomic library to obtain the mouse ATH-3 gene (Isaka 1996) and Atonal (Jarman et al., 1993) in the bHLH domain ( Figure 2B ), suggesting that these factors share a et al., 1996) . By using this ATH-3 genomic clone as a , Xenopus ATH-3 (XATH-3) and other HLH factors. The positions of the basic region, helices 1 and 2 and the loop are indicated above. The conserved residues in comparison with ATH-3 are shown in bold. The identity (%) to MATH-3 is indicated on the right. Sources for sequences are as follows: mouse MATH-1 ; mouse MATH-2 (Bartholomä and Nave, 1994; Shimizu et al., 1995) ; mouse NeuroD (Lee et al., 1995) ; mouse NDRF (Yasunami et al., 1996) ; Drosophila Atonal (Jarman et al., 1993) ; rat Mash-1 (Johnson et al., 1990) ; rat Mash-2 (Johnson et al., 1990) ; Xenopus Xash-3 (Zimmerman et al., 1993) ; rat HES-1 ; human E47 (Murre et al., 1989) ; mouse MyoD ; mouse Id-1 (Benezra et al., 1990) ; and human N-myc (Kohl et al., 1986) . recent common ancestral gene. However, unlike the latter residue in the basic region and that its phosphorylation inactivates the myogenic activity (Li et al., 1992) . Thus, factors, ATH-3 contained serine (amino acid residue 89 in Xenopus) or threonine (98 in mouse) in the basic region, the activity of ATH-3 could also be regulated by phosphorylation and dephosphorylation of the basic region. which forms a potential phosphorylation site. It has been shown that myogenic bHLH factors contain a threonine Another structural feature common to Xenopus and mouse ATH-3 is the acidic region (Glu-Asp stretch; amino acid expressed at high levels in the trigeminal ( Figure 4C , arrow) and dorsal root ganglions ( Figure 4D ) and the residues 38-56 of Xenopus and 49-65 of mouse) and the basic region (Lys-Arg stretch; amino acid residues 57-72 ventral part of the midbrain and hindbrain (data not shown). At E12.5, ATH-3 expression was detected in the of Xenopus and 66-81 of mouse), which are located upstream of the bHLH domain. These acidic and basic mantle layer of the brain and spinal cord, trigeminal ganglion, Rathke's pouch, dorsal root ganglion and the regions are also present in MATH-2, NeuroD and NDRF, and could be involved in transcriptional activity. ventricular zone of the neural retina ( Figure 4F and H). At E16.5, the expression persisted at a high level in the diencephalon ( Figure 4J ) and the neural retina ( Figure 4L ) Spatial and temporal distribution of ATH-3 The spatiotemporal expression patterns of ATH-3 were but decreased to quite low levels in other regions. Thus, ATH-3 expression initially occurred widely in the nervous determined by in situ hybridization. In Xenopus, ATH-3 expression was first detected weakly at stage 12 in two system but then became restricted to the anterior region in mouse embryos, indicating that Xenopus and mice show stripes within the presumptive neural plate ( Figure 3A , arrowheads). At stage 14, ATH-3 was expressed in three somewhat similar patterns of spatiotemporal expression. Northern blot analysis demonstrated that a high level stripes on both sides of the midline of the neural plate ( Figure 3B , arrowheads). Assessed by their positions, cells of ATH-3 expression continued after birth to adulthood in mouse retina ( Figure 5A ). In situ hybridization analysis in these stripes may correspond to primary neuronal precursors, which differentiate into motor and sensory showed that ATH-3 was expressed in the outer half of the ventricular zone at postnatal day (P) 0 ( Figure 5B ). During neurons and interneurons. At stages 18 and 21, strong ATH-3 expression appeared in the cranial ganglions ( Figure  P3 -P5, the inner (INL) and outer nuclear layers (ONL) develop in the retina and, after this stage, ATH-3 expression 3C and D, arrowheads) while weaker expression remained in the spinal cord. Later, ATH-3 was expressed strongly continued in the INL ( Figure 5B ), indicating that mature retinal neurons also expressed ATH-3. In adults, ATH-3 in the eye, forebrain and cranial ganglions, where active neuronal differentiation occurs ( Figure 3E and F). Thus, was not expressed in any other tissues that we examined ( Figure 5A and data not shown). Thus, ATH-3 expression ATH-3 initially may be expressed in neural progenitor cells and later in differentiating post-mitotic neurons of persisted in the neural retina from E9.5 onwards, suggesting that ATH-3 may be involved not only in the the anterior nervous system in Xenopus embryos.
In mice, weak expression of ATH-3 initially was detected development but also in the maintenance of retinal cells. widely in the neural tube around embryonic day (E) 8.5, before the process of turning ( Figure 4A ). By E9.5, ATH-3
Neural hyperplasia by injection of ATH-3 RNA To assess the function of ATH-3 in neural development, expression had become prominent in the ventral part of the brain and spinal cord ( Figure 4B ) and initiated weakly in vitro generated Xenopus ATH-3 RNA was injected into Xenopus embryos. When 50 or 100 pg of ATH-3 RNA in the retina (data not shown). At E10.5, ATH-3 was was injected into one cell of two-cell stage Xenopus arrow). This ATH-3 phenotype of neural tube enlargement is different from that of NeuroD, which does not cause embryos, the most notable and frequent phenotype was expansion of the CNS on the injected side (Table I) . Coneural tube hyperplasia (Lee et al., 1995) , but seems quite similar to that of XASH-3, which expands the neural tube injection of β-galactosidase RNA allowed us to confirm the injected side by X-gal staining (data not shown). (Ferreiro et al., 1994; Turner and Weintraub, 1994) . In addition to the expanded neural tube, ectopic NEU-1 or Immunological analyses with the pan-neural marker NEU-1 (Itoh and Kubota, 1989) showed that the neural neural cell adhesion molecule (N-CAM) staining was detected in the epidermis on the injected side ( Figure 6B , tube was significantly enlarged laterally at stages 25 and 30 ( Figure 6A and B, arrowheads). The optic cup was G and H). Ectopic neurogenesis was also induced in the epidermis when ATH-3 RNA was injected into a ventral deformed and displaced on the injected side ( Figure 6B , ( Figure 6I , arrowhead), and the eye was deformed and displaced ventrally on the injected side. Histological analyses revealed that the forebrain dramatically expanded laterally and anteriorly on the injected side ( Figure 6J , arrowheads). As a result, the development of the surrounding regions was disturbed. The hindbrain was also expanded by overexpression of ATH-3 ( Figure 6K , arrowheads). Because the injected ATH-3 RNA was likely to have disappeared by this time, the above results indicate that neural hyperplasia remained permanently by transient expression of ATH-3. The observed neural hyperplasia could be due to either cell proliferation or conversion of surrounding non-neural cells to a neural fate. To distinguish between these possibilities, cell division of ATH-3 RNA-injected embryos was blocked by hydroxyurea/aphidicolin (HUA) treatment at mid-gastrulation. It has been shown that embryos treated with HUA at mid-gastrulation stop cell division but develop almost normally until tailbud stages (Harris and Hartenstein, 1991; Turner and Weintraub, 1994) . As shown in Figure 6C , ATH-3 overexpression expanded the CNS and induced ectopic neurogenesis in the epidermis on the injected side even in the presence of HUA. Thus, cell proliferation is not necessary for neural hyperplasia induced by ATH-3, suggesting that overexpression of ATH-3 converts adjacent non-neural cells to a neural fate. possibility, we next determined expression of non-neural markers in the injected embryos. On the ATH-3 RNAinjected side, expression of twist, a marker for non-neural cell of four-cell stage embryos ( Figure 6E ). Ectopic NEU-1-positive cells in the epidermis showed the morphotypes of neural crest cells (Hopwood et al., 1989; Turner and Weintraub, 1994) , was severely reduced (Figure 7B logy of neurons with multiple processes ( Figure 6E ). This ATH-3 phenotype is quite similar to that of NeuroD, which and C), suggesting that ectopic ATH-3 expression decreased the population of neural crest cells with the ectopically converts neural crest and epidermal cells into neurons (Lee et al., 1995) . These results suggest that potential to differentiate into non-neural cells. These cells may instead become ectopic neurons, which were observed ATH-3 cannot only expand the neural tube like XASH-3 but can also induce ectopic neurogenesis in the epidermis in the epidermis of ATH-3 RNA-injected embryos (see Figure 6E , G and H). like NeuroD.
At the tadpole stage, the brain was significantly enlarged In the injected embryos, expression of keratin, an The hindbrain is expanded laterally (arrowheads) on the injected side (ϩ). CG, cement gland; H, heart; HB, hindbrain; N, notochord; Ot, otic vesicle.
epidermal marker (Jonas et al., 1985) , was also significActivation of neural gene expression in animal caps by ATH-3 antly reduced ( Figure 7E and F) . In addition, somite formation was also severely blocked, as revealed by
To assess more clearly the ATH-3 function in neurogenesis, additional markers were examined in the injected embryos. impaired myosin expression ( Figure 7H, arrows) . These results support the hypothesis that ATH-3 expands the The ATH-3 RNA was injected into both cells of two-cell stage Xenopus embryos, and subsequently the animal caps neural tissues at the expense of adjacent non-neural cells. were isolated from the injected embryos at stage 9. These neural marker XlHbox6 (Wright et al., 1990) and the floor-plate marker F-spondin (Ruiz i Altaba et al., 1993) explants were cultured for an additional 3 h (equivalent to stage 11), 1 day (stages 25-30) or 3 days (stages 35-were not induced by ATH-3 (Figure 8, lane 3) . Thus, ATH-3 can promote development of neurons with anterior 40). Uninjected animal caps are known to become atypical epidermis and, therefore, neural and mesodermal markers features, suggesting that ATH-3 may have a role in specification of anterior neuronal types. This neural inducwere not expressed ( Figure 8, lane 2) . In contrast, injection of ATH-3 RNA induced significant expression of the pantion by ATH-3 was also observed when the culture was continued for 3 days (equivalent to stages 35-40) (data neural marker N-CAM (Kintner and Melton, 1987) and the neuronal markers type-II β-tubulin (Good et al., 1989) not shown), indicating that the activation of neural gene expression by ATH-3 is stable. This is in sharp contrast and neurofilament-M (NF-M) (Sharpe, 1988) in stage 25-30 animal caps (Figure 8, lane 3) , indicating that ATH-3 to the action of XASH-3, which only transiently induces neural gene expression in animal caps (Ferreiro et al., can induce neuronal differentiation. In addition, expression of the anterior neural markers XANF-1 (Zaraisky et al., 1994) . In ATH-3 RNA-injected animal caps, expression of 1992) and XIF-3 (Sharpe et al., 1989) and the retinal marker opsin (Saha and Grainger, 1993) was also significmesodermal markers was not detected; Xbra and goosecoid (Blumberg et al., 1991) were not antly induced in ATH-3 RNA-injected animal caps ( Figure  8, lane 3) . However, other markers such as the posterior expressed in the animal cap explants that had been cultured
These results indicate that Ser89 is critical for the regulation of ATH-3 activity by phosphorylation and that modification of a single amino acid residue in the basic region can regulate some of the neurogenic activities of a bHLH factor.
Discussion
ATH-3 may function in both determination and differentiation steps of Xenopus neural development In this study, we showed that overexpression of ATH-3 can induce ectopic neurons and hyperplasia of the CNS but suppress development of non-neural tissues in Xenopus embryos. Interestingly, ATH-3-induced neural hyperplasia does not require cell division, indicating that the adjacent non-neural lineage cells adopt a neural fate. In addition, ATH-3 can induce neurons without inducing mesoderm in the animal cap assay. These results provide evidence that ATH-3 can directly convert non-neural or undetermined cells into neurons. It has been proposed that there are at least two separate developmental choices for generation of neurons in vertebrates; first, whether or not to adopt a neural lineage, and second, whether or not to differentiate as a neuron (Ferreiro et al., 1994; Turner and Weintraub, 1994; Lee et al., 1995) . The first step involves the initial decision between the neural tube and disturbance of development of the surrounding non-neural tissues. These results suggest that, like XASH-3, ATH-3 can function as a proneural gene in for 3 h (data not shown). In addition, S-actin (Stutz and Spohr, 1986) was not expressed in the injected animal Xenopus embryos. The early onset of ATH-3 expression before the neural plate appears is also consistent with the caps that had been cultured for 1 day (equivalent to stages 25-30) (Figure 8 lane 3) . Thus, ATH-3 promoted neuronal notion that ATH-3 is a proneural gene. Interestingly, whereas in animal cap assays XASH-3 can only transiently differentiation without inducing mesoderm, suggesting that ATH-3 may directly convert ectodermal cells into neurons.
induce neural gene expressions and requires the neural inducer noggin for stable induction (Ferreiro et al., 1994) , ATH-3 can stably induce neural gene expression without Modification of ATH-3 activities by a single amino acid change in the basic region noggin. Thus, ATH-3 seems to have a stronger neurogenic activity than XASH-3, or ATH-3 may be less susceptible Among the vertebrate neural bHLH factors that have been characterized, ATH-3 has a unique structural feature; a to inhibitory signals such as Notch and HES-1. Another bHLH gene, NeuroD, regulates the terminal serine or threonine residue in the basic region ( Figure  2B ), which forms a potential phosphorylation site. As an differentiation step of neural development. It has been shown that NeuroD can induce ectopic neural tissues in initial step in relating the possible phosphorylation to the neurogenic activity of ATH-3, a Ser89→Asp mutation was the epidermis of Xenopus embryos. ATH-3 also induces ectopic neural tissues in the epidermis, like NeuroD, introduced into Xenopus ATH-3 (S89D), which mimics the phosphorylation of Ser. Another mutation was also suggesting that ATH-3 and NeuroD have similar neurogenic functions. Furthermore, ATH-3 is expressed at a high introduced to change Ser89 to Asn (S89N), which could represent a non-phosphorylated form. On the animal cap level in the nervous system during neuronal differentiation stages, suggesting that ATH-3 can also act as a NeuroDanalysis, S89D was able to induce N-CAM, type II β-tubulin and NF-M expression (Figure 8, lane 4) , indicatlike differentiation gene. Thus, ATH-3 may function in both proneural and neuronal differentiation stages in ing that S89D keeps the general neurogenic activities. However, it failed to induce the anterior neural markers Xenopus embryos. In the case of mice, the ATH-3 function remains to be XANF-1 and opsin (Figure 8, lane 4) . In contrast, S89N induced anterior neural gene expression as well as general determined. Because ATH-3 expression starts around E8.5 in the neural tube, after the neural lineage is mainly neural markers, like wild type ATH-3 (Figure 8, lane 5) .
determined, ATH-3 may function primarily in neuronal ATH-3 and Pax-6 may constitute different genetic pathways for retinal development. Because only a part of the differentiation stages.
Pax-6 expression domains becomes retina, it has been suggested that another factor not regulated by Pax-6 ATH-3 activity may be regulated by phosphorylation of Ser (or Thr) in the basic region may be required for retinal specification (Macdonald and Wilson, 1996) . Thus, our findings that ATH-3 can induce ATH-3 has a serine or threonine residue in the basic region, which could serve as a phosphorylation site. Other opsin expression suggest that ATH-3 may have an independent function in the process of retinal specification neural bHLH factors contain asparagine or arginine in the corresponding position, thus indicating that the amino acid within Pax-6-expressing regions. residue in this position is not conserved among the neural bHLH factors ( Figure 2B) . Interestingly, the myogenic
Materials and methods
bHLH factors contain a threonine residue in the basic region, and it has been shown that its phosphorylation Isolation of the mouse ATH-3 gene and cDNA Oligo(dT)-primed cDNA was prepared from E9.5 mouse CNS and inactivates the myogenic activities (Li et al., 1992) . Change subjected to PCR with fully degenerate oligonucleotide primers corresfrom Thr to Asp, which mimics the phosphorylation in ponding to the amino acid sequences NARER and TLQMA of Atonal, the basic region of myogenin, causes loss of DNA binding as previously described Shimizu et al., 1995) . and myogenic activities (Brennan et al., 1991) . In the case
We subcloned and sequenced the amplified fragments, and obtained the ATH-3 sequence. The PCR clone of ATH-3 was labelled with of Xenopus ATH-3, mutation of Ser89 to Asp (S89D) [α-32 P] dCTP by a random primer method and used as a probe for maintains a general neurogenic activity but severely screening a mouse genomic library (Stratagene) (Takebayashi et al., impairs anterior marker-inducing abilities in the Xenopus quite interesting, and we can offer two possibilities. One
In situ hybridization and Northern blot analysis of ATH-3
is that S89D could lose the DNA binding activity and
In situ hybridization experiments were performed, essentially as described titrate negative regulators by forming a non-DNA binding previously (Harland, 1991; Hatada et al., 1995; heterodimer complex, thereby activating gene expression.
1995). Digoxigenin-labelled antisense RNAs corresponding to the 658
The other possibility is that the DNA binding specificity bp PvuII-HindIII mouse ATH-3 genomic fragment and the 634 bp XbaIEcoRI Xenopus ATH-3 cDNA fragment were synthesized in vitro. These of S89D could be changed by addition of a negative probes were hybridized to whole mouse embryos, 10 mm cryostat charge in the basic region; it could bind to the promoter sections or Xenopus albino embryos.
of general neural genes but not of anterior genes. DeterFor Northern blot analysis, 15 μg of total RNA was electrophoresed mination of ATH-3 binding sequences will be necessary on a formamide/1.2% agarose gel and transferred to a nylon membrane.
to address these problems.
The filter was hybridized at 42°C with the 32 P-labelled HincII-EcoRI fragment of mouse ATH-3 cDNA and washed, as previously described .
ATH-3 in retinal development
It is striking that ATH-3, expressed at a high level in the Analysis of RNA-injected Xenopus embryos retina, can induce opsin expression in the animal cap
The full-length coding region of the Xenopus ATH-3 cDNA was subcloned into pSP64T vector, and capped ATH-3 RNA was produced assay, raising the possibility that ATH-3 may be involved in vitro as described before (Krieg and Melton, 1984) . The ATH-3 and in retinal specification. However, induction of anterior β-galactosidase RNAs were injected into one cell of two-cell or fourneural markers by ATH-3 could reflect a general property cell stage Xenopus embryos. At various stages, the injected embryos of Xenopus ectoderm, since neural inducers like noggin, were subjected to histological study with haematoxylin-eosin (HE) chordin and follistatin also induce a similar spectrum of staining, immunological study with NEU-1 monoclonal antibody (Itoh and Kubota, 1989 ) and anti-myosin monoclonal antibody MF 20 (Bader anterior markers (Lamb et al., 1993; Hemmati-Brivanlou et al., 1982) or in situ hybridization of N-CAM, twist and keratin. The and Melton, 1994; Sasai et al., 1995) . Nevertheless, we probe regions for N-CAM, twist and keratin are nucleotide residues speculate that the opsin-inducing activity may be an 1466-2020 (Accession nos. M76710), 155-652 (M27730) and intrinsic property of ATH-3, because S89D loses the opsin-(M11940), respectively. To identify the injected side, X-gal staining was performed.
inducing ability but maintains general neurogenic activities For HUA treatment, injected embryos were transferred to 20 mM in the animal cap assay. hydroxyurea-0.15 mM aphidicolin at stage 10.5, as previously described Eye morphogenesis is known to be regulated by the (Harris and Hartenstein, 1991). eye master control gene Pax-6 (Halder et al., 1995) , and it is possible, therefore, that ATH-3 expression is regulated
Xenopus animal cap assay
Mutations were introduced into ATH-3 cDNA by hybridizing oligoby Pax-6. However, ATH-3 was similarly expressed in the nucleotides 5Ј-AAGTCCATGCATTCTATCACGCTCCCTGGCATTG optic vesicles of wild-type and Small eye mutant mice, which have a Pax-6 mutation (Hill et al., 1991; Walther GC-3Ј with heat-denatured ATH-3 cDNA for S89D and S89N, respectand Gruss, 1991), indicating that ATH-3 expression does ively. Each mutant was cloned into pSP64T and sequenced.
In vitro synthesized ATH-3, S89D or S89N RNA was injected into not depend upon Pax-6 (our unpublished data). Thus,
